Banque Cantonale Vaudoise Sells 11,114 Shares of The Clorox Company $CLX

Banque Cantonale Vaudoise lowered its holdings in shares of The Clorox Company (NYSE:CLX) by 50.4% during the first quarter, Holdings Channel reports. The institutional investor owned 10,958 shares of the company’s stock after selling 11,114 shares during the quarter. Banque Cantonale Vaudoise’s holdings in Clorox were worth $1,136,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. State Street Corp lifted its stake in Clorox by 3.5% during the third quarter. State Street Corp now owns 8,434,277 shares of the company’s stock worth $1,039,946,000 after purchasing an additional 282,794 shares during the period. Invesco Ltd. boosted its holdings in Clorox by 22.1% during the fourth quarter. Invesco Ltd. now owns 4,880,341 shares of the company’s stock valued at $492,085,000 after purchasing an additional 884,751 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Clorox by 0.3% in the 4th quarter. Geode Capital Management LLC now owns 3,172,233 shares of the company’s stock valued at $318,613,000 after purchasing an additional 10,060 shares during the period. Van ECK Associates Corp raised its holdings in shares of Clorox by 15.7% in the 4th quarter. Van ECK Associates Corp now owns 3,136,405 shares of the company’s stock worth $316,244,000 after buying an additional 426,433 shares in the last quarter. Finally, Two Sigma Investments LP raised its holdings in shares of Clorox by 33.8% in the 3rd quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock worth $214,564,000 after buying an additional 439,797 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Trading Up 2.4%

CLX stock opened at $97.51 on Friday. The business has a fifty day moving average price of $94.67 and a 200 day moving average price of $104.43. The Clorox Company has a fifty-two week low of $84.70 and a fifty-two week high of $132.03. The stock has a market capitalization of $11.79 billion, a price-to-earnings ratio of 15.83, a P/E/G ratio of 0.51 and a beta of 0.56. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.55 by $0.09. The firm had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The business’s revenue for the quarter was up .1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Analysts expect that The Clorox Company will post 5.61 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

CLX has been the topic of several recent analyst reports. Zacks Research lowered Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, May 12th. Barclays dropped their price objective on Clorox from $102.00 to $85.00 and set an “underweight” rating for the company in a research note on Friday, May 1st. JPMorgan Chase & Co. reduced their target price on shares of Clorox from $99.00 to $95.00 and set an “underweight” rating on the stock in a research note on Friday, May 1st. Wells Fargo & Company lowered their target price on shares of Clorox from $100.00 to $95.00 and set an “equal weight” rating on the stock in a report on Monday, May 18th. Finally, Weiss Ratings upgraded shares of Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, April 13th. One equities research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Reduce” and an average price target of $103.40.

Insider Buying and Selling at Clorox

In other Clorox news, Director Pierre R. Breber bought 5,000 shares of the business’s stock in a transaction on Tuesday, May 5th. The shares were bought at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the transaction, the director owned 18,000 shares in the company, valued at approximately $1,544,760. This trade represents a 38.46% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.63% of the stock is currently owned by insiders.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.